関連する実験動画
Updated: Sep 9, 2025
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
347
肥満に関連した喘息を持つ様々な参加者の間で,費用関連の薬剤使用の障壁
Luyu Xie1, Joohan Kim2, Jaime P Almandoz3
1Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas.
Journal of managed care & specialty pharmacy
|August 30, 2025
まとめ
肥満に関連した喘息を持つ人は 高い薬費の障壁に直面します それにもかかわらず 肥満に関連した喘息を持つ黒人やヒスパニックの患者は 白人の患者よりも薬の服用を控える可能性が低いのです
科学分野:
- 肺医学
- 医療サービス研究
- 健康 の 格差
背景:
- 肥満に関連した喘息 (OAA) は,健康的な体重の喘息と比較して,より悪い健康結果と関連しています.
- 医療従事者における医療従事者への服薬へのコストバリアの影響は,特に異なる人種や民族のグループにおける影響は,まだ十分に検討されていない.
研究 の 目的:
- OAAの成人の薬物使用に対するコスト関連の障壁の影響を調査する.
- これらのコストの障壁と薬物の使用パターンが 人種や民族によってどのように異なるかを分析する.
主な方法:
- "All of Us"プログラム (2017年5月〜2024年8月) のデータを活用した横断的な研究が行われました.
- 肥満に関連した喘息 (OAA) は,電子医療記録で確認された喘息とBMI ≥30 kg/ m2によって定義された.
- 薬物使用に対する自己報告されたコスト関連の障壁が主な結果の指標でした.
主要な成果:
- この研究では,成人喘息患者21, 108人が参加し,そのうち51. 7%がOAA (平均BMI38. 6kg/ m2) であった.
- OAA患者の場合,費用関連の障壁が発生する確率は高かった (aOR 1. 121. 31,P < 0. 05).
- 非ヒスパニック系黒人とヒスパニック系OAAの人は,手頃な価格の問題に直面しているにもかかわらず,薬剤をスキップする確率は低い (aOR 0.82,P=0.013;aOR 0.80,P=0.033,それぞれ) で,非ヒスパニック系白人と比較して,より低コストの代替品を要求している.
結論:
- OAA患者の費用に関する障壁において,有意な人種的および民族的差異が特定されました.
- これらの発見は,多様な集団の健康格差を軽減し,喘息の管理を強化するために,文化に合わせた医療介入の必要性を強調しています.
関連する概念動画
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:24Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
377
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
377
01:23Inhaled Medications
388
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
388
01:26COPD: Management Using Bronchodilators and Corticosteroids
305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305